• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

电子健康记录(EHRs)用于预测初级保健中慢性呼吸道疾病控制不佳的临床前评估:一种集中我们努力的新方法。

Preclinical Evaluation of Electronic Health Records (EHRs) to Predict Poor Control of Chronic Respiratory Diseases in Primary Care: A Novel Approach to Focus Our Efforts.

作者信息

Navarro Ros Fernando M, Maya Viejo José David

机构信息

Centro de Salud Malilla, Carrer de Malilla 52D, Quatre Carreres, 46026 Valencia, Spain.

Centro de Salud de Camas, Santa Maria de Gracia 54, 41900 Camas, Spain.

出版信息

J Clin Med. 2024 Sep 21;13(18):5609. doi: 10.3390/jcm13185609.

DOI:10.3390/jcm13185609
PMID:39337095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11433338/
Abstract

Managing chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) within the Spanish (SNS) presents significant challenges, particularly due to their high prevalence and poor disease control rates-approximately 45.1% for asthma and 63.2% for COPD. This study aims to develop a novel predictive model using electronic health records (EHRs) to estimate the likelihood of poor disease control in these patients, thereby enabling more efficient management in primary care settings. The Seleida project employed a bioinformatics approach to identify significant clinical variables from EHR data in primary care centers in Seville and Valencia. Statistically significant variables were incorporated into a logistic regression model to predict poor disease control in patients with asthma and COPD patients. Key variables included the number of short-acting β-agonist (SABA) and short-acting muscarinic antagonist (SAMA) canisters, prednisone courses, and antibiotic courses over the past year. The developed model demonstrated high accuracy, sensitivity, and specificity in predicting poorly controlled disease in both asthma and COPD patients. These findings suggest that the model could serve as a valuable tool for the early identification of at-risk patients, allowing healthcare providers to prioritize and optimize resource allocation in primary care settings. Integrating this predictive model into primary care practice could enhance the proactive management of asthma and COPD, potentially improving patient outcomes and reducing the burden on healthcare systems. Further validation in diverse clinical settings is warranted to confirm the model's efficacy and generalizability.

摘要

在西班牙国家卫生系统(SNS)中管理哮喘和慢性阻塞性肺疾病(COPD)等慢性呼吸道疾病面临重大挑战,特别是由于其高患病率和疾病控制率低——哮喘约为45.1%,COPD约为63.2%。本研究旨在开发一种使用电子健康记录(EHR)的新型预测模型,以估计这些患者疾病控制不佳的可能性,从而在初级保健环境中实现更有效的管理。Seleida项目采用生物信息学方法,从塞维利亚和巴伦西亚初级保健中心的EHR数据中识别重要的临床变量。具有统计学意义的变量被纳入逻辑回归模型,以预测哮喘患者和COPD患者的疾病控制不佳情况。关键变量包括过去一年中短效β-激动剂(SABA)和短效毒蕈碱拮抗剂(SAMA)吸入器的使用数量、泼尼松疗程和抗生素疗程。所开发的模型在预测哮喘和COPD患者疾病控制不佳方面显示出高准确性、敏感性和特异性。这些发现表明,该模型可作为早期识别高危患者的有价值工具,使医疗保健提供者能够在初级保健环境中优先安排并优化资源分配。将这种预测模型整合到初级保健实践中可以加强对哮喘和COPD的主动管理,有可能改善患者预后并减轻医疗系统的负担。有必要在不同临床环境中进行进一步验证,以确认该模型的有效性和通用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/3cd45434895f/jcm-13-05609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/fe30c794b33c/jcm-13-05609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/2d91ee4c63dc/jcm-13-05609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/4351f59e1d6c/jcm-13-05609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/3cd45434895f/jcm-13-05609-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/fe30c794b33c/jcm-13-05609-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/2d91ee4c63dc/jcm-13-05609-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/4351f59e1d6c/jcm-13-05609-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b8b/11433338/3cd45434895f/jcm-13-05609-g004.jpg

相似文献

1
Preclinical Evaluation of Electronic Health Records (EHRs) to Predict Poor Control of Chronic Respiratory Diseases in Primary Care: A Novel Approach to Focus Our Efforts.电子健康记录(EHRs)用于预测初级保健中慢性呼吸道疾病控制不佳的临床前评估:一种集中我们努力的新方法。
J Clin Med. 2024 Sep 21;13(18):5609. doi: 10.3390/jcm13185609.
2
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.在使用 OpenSAFELY 平台的观察性队列研究中,接受吸入皮质类固醇治疗的慢性阻塞性肺疾病或哮喘患者发生 COVID-19 相关死亡的风险。
Lancet Respir Med. 2020 Nov;8(11):1106-1120. doi: 10.1016/S2213-2600(20)30415-X. Epub 2020 Sep 24.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
Exploring the appropriateness of prescribing practice of inhaled pharmacotherapy among Aboriginal Australians in the Top End Northern Territory of Australia: a retrospective cohort study.探索澳大利亚北部顶端地区的澳大利亚原住民使用吸入性药物治疗的处方实践是否合适:一项回顾性队列研究。
BMJ Open Respir Res. 2023 Mar;10(1). doi: 10.1136/bmjresp-2022-001508.
5
6
UK Electronic Healthcare Records for Research: A Scientometric Analysis of Respiratory, Cardiovascular, and COVID-19 Publications.英国用于研究的电子医疗记录:呼吸、心血管及新冠病毒疾病出版物的科学计量分析
Pragmat Obs Res. 2024 Aug 15;15:151-164. doi: 10.2147/POR.S469973. eCollection 2024.
7
Association between Inhaled β-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study.吸入β-激动剂与主要不良心血管事件风险的关联:基于人群的巢式病例对照研究。
Int J Chron Obstruct Pulmon Dis. 2022 May 20;17:1205-1217. doi: 10.2147/COPD.S358927. eCollection 2022.
8
A Natural Language Processing Model for COVID-19 Detection Based on Dutch General Practice Electronic Health Records by Using Bidirectional Encoder Representations From Transformers: Development and Validation Study.基于荷兰全科电子健康记录的 COVID-19 检测自然语言处理模型:使用转换器的双向编码器表示进行开发和验证研究。
J Med Internet Res. 2023 Oct 4;25:e49944. doi: 10.2196/49944.
9
The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).哮喘-慢性阻塞性肺疾病重叠综合征(ACOS)的药理学管理。
Expert Opin Pharmacother. 2020 Feb;21(2):213-231. doi: 10.1080/14656566.2019.1701656.
10

引用本文的文献

1
Too Much SAMA, Too Many Exacerbations: A Call for Caution in Asthma.过多的短效抗胆碱能药物,过多的急性加重:哮喘治疗需谨慎呼吁
J Clin Med. 2025 Jul 16;14(14):5046. doi: 10.3390/jcm14145046.
2
Preclinical Identification of Poorly Controlled COPD: Patients with a Single Moderate Exacerbation Matter Too.控制不佳的慢性阻塞性肺疾病的临床前识别:单次中度加重的患者也很重要。
J Clin Med. 2024 Dec 24;14(1):22. doi: 10.3390/jcm14010022.
3
Improving GPs' Emotional Intelligence and Resilience to Better Manage Chronic Respiratory Diseases Through an Experiential Online Training Intervention: A Mixed Methods Study.

本文引用的文献

1
Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks.利用电子健康记录描述两大医疗系统网络中未控制的高血压患者的特征。
BMC Cardiovasc Disord. 2024 Sep 18;24(1):497. doi: 10.1186/s12872-024-04161-x.
2
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States.美国未控制的严重哮喘患者中的护理差距。
J Allergy Clin Immunol Pract. 2024 Jul;12(7):1775-1782.e2. doi: 10.1016/j.jaip.2024.03.018. Epub 2024 Mar 18.
3
The Burden of Chronic Disease.慢性病的负担
通过体验式在线培训干预提高全科医生的情商和恢复力以更好地管理慢性呼吸道疾病:一项混合方法研究
Healthcare (Basel). 2024 Dec 25;13(1):21. doi: 10.3390/healthcare13010021.
Mayo Clin Proc Innov Qual Outcomes. 2024 Jan 20;8(1):112-119. doi: 10.1016/j.mayocpiqo.2023.08.005. eCollection 2024 Feb.
4
GOLD COPD report: 2024 update.慢性阻塞性肺疾病全球倡议(GOLD)报告:2024年更新版
Lancet Respir Med. 2024 Jan;12(1):15-16. doi: 10.1016/S2213-2600(23)00461-7. Epub 2023 Dec 4.
5
Global Burden of Chronic Obstructive Pulmonary Disease Through 2050.全球慢性阻塞性肺疾病负担研究报告 2050 年展望
JAMA Netw Open. 2023 Dec 1;6(12):e2346598. doi: 10.1001/jamanetworkopen.2023.46598.
6
Basis of preventive and non-pharmacological interventions in asthma.哮喘的预防和非药物干预基础。
Front Public Health. 2023 Oct 18;11:1172391. doi: 10.3389/fpubh.2023.1172391. eCollection 2023.
7
Effects of pharmacological and non-pharmacological interventions on physical activity outcomes in COPD: a systematic review and meta-analysis.药物和非药物干预对慢性阻塞性肺疾病身体活动结果的影响:一项系统评价和荟萃分析。
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00409-2023. eCollection 2023 Sep.
8
Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option.COPD 患者的临床控制缺乏(取决于目标和治疗选择)。
Int J Chron Obstruct Pulmon Dis. 2023 Jul 6;18:1367-1376. doi: 10.2147/COPD.S414910. eCollection 2023.
9
High use of short-acting β-agonists in COPD is associated with an increased risk of exacerbations and mortality.慢性阻塞性肺疾病(COPD)患者频繁使用短效β受体激动剂与急性加重和死亡风险增加有关。
ERJ Open Res. 2023 Jun 19;9(3). doi: 10.1183/23120541.00722-2022. eCollection 2023 May.
10
Editorial: Aging and chronic disease: public health challenge and education reform.社论:衰老与慢性病:公共卫生挑战与教育改革
Front Public Health. 2023 May 9;11:1175898. doi: 10.3389/fpubh.2023.1175898. eCollection 2023.